Essential mycobacterial gene glmM as an immunotherapeutic target against tuberculosis
Vinay Nandicoori,
Meetu Agarwal,
Ved Prakash Dwivedi
et al.
Abstract:The limitations of TB treatment are the long duration and immune-dampening effects of anti-tuberculosis therapy. The cell wall of mycobacteria helps in its survival, pathogenicity, and virulence and provides resistance against different antibiotics. Hence, cell wall biosynthesis pathways and the enzymes involved are crucial and, thus, are good therapeutic targets. Here, we identify Mycobacterium tuberculosis (Mtb) GlmM, (GlmMMtb) involved in the UDP-GlcNAc synthesis pathway as an essential enzyme. Using the CR… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.